In this context, biochemical biomarkers, namely procalcitonin (PCT) alone [7, 8] or integrating a composite panel [9–12], and always coupled with thorough clinical examination, may be an important aid for the early suspicion of sepsis and rapid institution of therapy, which is strongly associated with improved outcomes [13, 14]. This evidence concerns the gene CALCA and Sepsis.